Tech Company Financing Transactions
Celcuity Funding Round
Celcuity, based in Minneapolis, received $750 thousand in investment from Brightstone Venture Capital.
Transaction Overview
Company Name
Announced On
3/31/2014
Transaction Type
Venture Equity
Amount
$750,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
16305 -- 36th Avenue North 450
Minneapolis, MN 55446
USA
Minneapolis, MN 55446
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Identifying the drug best suited to the specific biology of a patient s disease is beyond the capabilities of current genomic- or proteomic-based analyses. To fully realize the promise of personalized medicine, Celcuity has taken a different approach. Our CELx Pathway Profile tests analyze the functionality of a patient's diseased cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Sullivan
Chief Financial Officer
Vicky Hahne
Chief Scientific Officer
Lance Laing
Browse more venture capital transactions:
Prev: 3/31/2014: KAIZEN Platform venture capital transaction
Next: 3/31/2014: DAZ 3D venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs